Psychiatric Hospitals in the US
| Publication Date | April 2008 |
|---|---|
| Publisher | IBISWorld |
| Product Type | Report |
| Pages | 39 |
| ISBN Number | not applicable |
| Product Code | IBI01580 |
Summary
This industry comprises establishments known and licensed as psychiatric and substance abuse hospitals primarily engaged in providing diagnostic, medical treatment, and monitoring services for inpatients who suffer from mental illness or substance abuse disorders. The treatment often requires an extended stay in the hospital. These establishments maintain inpatient beds and provide patients with food services that meet their nutritional requirements. They have an organized staff of physicians and other medical staff to provide patient care services. Psychiatric, psychological, and social work services are available at the facility. These hospitals usually provide other services, such as outpatient services, clinical laboratory services, diagnostic X-ray services, and electroencephalograph services. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Content
- Industry Definition
- Activities (Products and Services)
- Similar Industries
- Other Related Industries
- Key Statistics
- Current Prices
- Constant Prices
- Real Growth
- Ratio Table
- Segmentation
- Products and Service Segmentation
- Major Market Segments
- Industry Concentration
- Geographic Spread
- Market Characteristics
- Market Size
- Linkages
- Demand Determinants
- Domestic and International Markets
- Basis of Competition
- Life Cycle
- Industry Conditions
- Barriers to Entry
- Taxation
- Industry Assistance
- Regulation and Deregulation
- Cost Structure
- Capital and Labor Intensity
- Technology and Systems
- Industry Volatility
- Globalization
- Key Factors
- Key Sensitivities
- Key Success Factors
- Key Competitors
- Major Players
- Player Performance
- Other Players
- Industry Performance
- Current Performance
- Historical Performance
- Outlook
About this Product
Delivery Details
PDF:Immediate delivery
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















